A comprehensive analysis of Staphylococcus aureus superantigen (SAG) genes was undertaken in isolates from a major hospital and compared with isolates from patients with toxic shock syndrome (TSS). Polymerase chain reaction (PCR) analysis included recently discovered SAGs. Staphylococcal enterotoxin (SE) G and SEI were uniquely expressed in genital isolates. Genital isolates were similar to TSS isolates, although the latter frequently expressed TSS toxin 1. Both had a high frequency of SEG/SEI and a high number of SAG genes per bacterium. Detection of an SAG gene by PCR correlated with positive results in functional assays for SAG activity. Levels of serum antibodies to SEG and SEI, but not to other superantigens, were higher in healthy women than in men and served as an independent measure of the higher frequency of exposure to SEG/SEI among women. Together, the data suggest a role for SEG/SEI or closely linked genes in the adaptation of S. aureus to the genital mucosa environment.
A comprehensive analysis of Staphylococcus aureus superantigen (SAG) genes was undertaken in isolates from a major hospital and compared with isolates from patients with toxic shock syndrome (TSS). Polymerase chain reaction (PCR) analysis included recently discovered SAGs. Staphylococcal enterotoxin (SE) G and SEI were uniquely expressed in genital isolates. Genital isolates were similar to TSS isolates, although the latter frequently expressed TSS toxin 1. Both had a high frequency of SEG/SEI and a high number of SAG genes per bacterium. Detection of an SAG gene by PCR correlated with positive results in functional assays for SAG activity. Levels of serum antibodies to SEG and SEI, but not to other superantigens, were higher in healthy women than in men and served as an independent measure of the higher frequency of exposure to SEG/SEI among women. Together, the data suggest a role for SEG/SEI or closely linked genes in the adaptation of S. aureus to the genital mucosa environment.
Superantigens (SAGs) are ∼25-kDa enterotoxins produced by microorganisms such as Staphylococcus aureus, Streptococcus pyogenes (group A), Yersinia pseudotuberculosis, and Mycoplasma arthritidis [1] . The staphylococcal toxins cause toxic shock syndrome (TSS) and food poisoning. SAGs are distinguished from conventional antigens. They do not require processing by antigen-presenting cells and bind to major histocompatibility complex class II at the cell surface at molecular sites other than the peptide-binding groove. They stimulate T cells based on the T cell receptor Vb gene expressed. This property explains their remarkable potency. Because relatively large percentages of T cells usually share expression of the same Vb gene, 10% of all T cells may respond to a given SAG. By contrast, the frequency of T cells responding to a nominal antigen is on the order of 10 Ϫ5 . The resulting high levels of cytokines stimulated by SAGs are thought to be the main cause of clinical toxic shock. S. aureus has at least 15 SAG genes, but there are only limited data available on the distribution of these genes among S. aureus clinical isolates [2] , and these studies did not examine the frequencies of the most recently described SAG genes. We know that isolates from patients with TSS always encode an SAG and frequently encode TSS toxin-1 (TSST1). However, little is known about other SAG genes.
Do S. aureus isolates differ in expression of these genes depending on whether they are associated with menstrual versus nonmenstrual TSS? Do SAG genes in isolates from patients with TSS differ from those in other S. aureus isolates and do they differ depending on tissue source? To answer some of these questions, we undertook a genomic survey of S. aureus isolates obtained at random from the clinical microbiology laboratories of a major metropolitan hospital. We tested for the presence of 12 SAG genes by polymerase chain reaction (PCR). Here, we describe our findings. were contributed by one of the authors (J.B.Z.) and have been described elsewhere [3] ; 4 TSS isolates were obtained from patients at New York Hospital: DE and CV were from pediatric patients with typical TSS, whereas BS44 and BS62 were from adult immunodeficient patients with an atypical presentation of TSS [4] .
PATIENTS, MATERIALS, AND METHODS

Patients
S. aureus isolates were obtained on brain-heart infusion (BHI) slants and subcloned on BHI agar plates prior to preparation of glycerol preps for storage. To prepare bacterial supernatants, the S. aureus isolates were thawed, and isolated colonies were cultured in Luria Bertani broth overnight. Bacteria then were pelleted by centrifugation in a microfuge, and supernatants were filtered through a 0.22-mm filter. These supernatants were frozen at Ϫ70ЊC for later use at indicated dilutions (usually 10 Ϫ3 -10 Ϫ6 ).
PCR analysis for SAGs.
For PCR analysis of bacterial DNA, we used the following primers (5 r3 ): SEA-F, TTGGAA-ACGGTTAAAACGAA; SEA-R, GAACCTTCCCATCAAAAA-CA (121-bp fragment amplified); SEB-F, TCGCATCAAACTG-ACAAACG; SEB-R, GCAGGTACTCTATAAGTGCC (477-bp fragment amplified); SEC-F, GTAATTTTGATATTCGCACT; SEC-R, TCATCTTTGTACTTCTTTGC (293-bp fragment amplified); SED-F, CTAGTTTGGTAATATCTCCT; SED-R, TAA-TGCTATATCTTATAGGG (318-bp fragment amplified); SEE-F, TAGATAAAGTTAAAACAAGC; SEE-R, TAACTTACCG-TGGACCCTTC (169-bp fragment amplified); TSST1-F, ATG-GCAGCATCAGCTTGATA; TSST1-R, TTTCCAATAACCAC-CCGTTT (350-bp fragment amplified); SEG-F, ACGTCTCC-ACCTGTTGAAGG; SEG-R, TGAGCCAGTGTCTTGCTTTG (400-bp fragment amplified); SEH-F, TTTCATTCACATC-ATATGCG; SEH-R, AAATCATTGCCACTATCACC (184-bp fragment amplified); SEI-F, TTGATACTGGAACAGGACAAG-C; SEI-R, ACACCAATATCACCTTGAGC (239-bp fragment amplified); SEJ-F, CTTTAGTTTACAGCGATAGC; and SEJ-R, TTATCTTTTCAGAGATACCC (138-bp fragment amplified).
We used previously characterized bacterial isolates as positive controls. A molecular clone, pZS2607, carrying SEJ [5] was also used as a control. An S. pyogenes isolate associated with TSS and various Staphylococcus epidermidis isolates were used as negative controls. Every experiment was run with both negative and positive controls. The PCRs were optimized in each case. In general, the 50-mL reactions contained 1.5-3.5 mM Mg, 0.2 U of Taq polymerase, 0.2 mM dNTPs, and 10-25 pmol of primer and were run for 36 cycles at 94ЊC for 1 min, 42-53ЊC for 1 min, and 72ЊC for 1 min.
[ 3 H]thymidine assay for SAG biologic activity. Peripheral blood lymphocytes (PBLs) were obtained from healthy subjects by Ficoll-Paque (Pharmacia) separation. The cells were washed 3 times in Hanks' medium and resuspended in RPMI 1640 medium with 10% fetal calf serum (FCS), antibiotics, and glutamine, at 10 6 cells/mL for culture, with bacterial supernatants diluted to 10 Ϫ3 -10 Ϫ6 . Cultures were checked for cell viability, which was usually 170% by trypan blue exclusion (toxicity of the supernatants was only observed at lesser dilutions). On day 3 of culture, cells were pulsed with 1 mCi of [ 3 H]thymidine (New England Nuclear) for 6 h and harvested onto filter mat glass fiber filter paper by cell harvester (Wallac). Beta emission was counted by betaplate liquid scintillation counter (Wallac).
Vb stimulation assay for biologic activity of SAG. PBLs were obtained from healthy subjects and cultured at 10 6 cells/ mL with dilutions of recombinant (r) SEG and rSEI at 10 Ϫ3 -10
Ϫ6
. Cells were also incubated with medium alone or with SEB as a positive control. After 3 days, we added 25 U/mL interleukin-2. After a total of 7 days, cells were stained with monoclonal antibody (MAb) to various Vb determinants [6] , as described elsewhere [7] . MAbs used were specific for Vb1 (clone BL37.2), Vb2 (E2.2E7.2), Vb3 (8F10), Vb5.1 (Immu157), Vb5.2 (36213), Vb6.7 (OT145), Vb7.1 (3G5.D5), Vb8 (MX3), Vb9.1 (FIN9), Vb11 (C21), Vb12 (S511), Vb13.1 (H131), Vb14 (CAS1.1.3), Vb16 (TAMAYA1.2), Vb17 (C1), Vb18 (BA62.6), Vb20 (Ell1.4), Vb21.3 (IG125), Vb22 (IMMU546), or Vb23 (HUT78#1). The cells were then washed 3 times and incubated with an optimal dilution of fluorescein isothiocyanate-labeled goat anti-mouse IgG antibody (Biosource International), followed by final washes and reading on a flow cytometer (EPICS II; Coulter).
ELISA for human antibodies to SAG. The assay was adopted from P. Schlievert (personal communication). We used SEA, SEB, SEC2, TSST1 (Toxin Technologies), rSEG (mMJB474), and rSEI (pMJB475), isolated as His-tagged proteins [8] . rSEG and rSEI were purified by growing bacteria MJB1323 and MJB1324, respectively (provided by S. Munson, University of Wisconsin, Madison), at 31ЊC in 1 L of Luria Bertani broth with ampicillin and kanamycin. The bacterial pellet was resuspended in 6 M GuHCl and stirred for 60 min. The lysate was centrifuged to harvest supernatant. The supernatant was mixed with Ni-NTA resin slurry (Qiagen) for 60 min, loaded into an empty column, Isolated proteins were coated onto plates (Nunc-Immuno [Maxisorp]; Nalge Nunc International) at 10-20 mg/mL in 0.1 M NaCO 3 (pH 9.0) buffer at 37ЊC until the wells were dry. The plates then were blocked with 2% FCS in PBS with 0.05% Tween 20 for 2 h at 37ЊC and washed with the same buffer 3 times. Serial 2-fold dilutions of human serum were added, starting at a dilution of 1:20, and the plates were incubated for 2 h at 37ЊC. The plates were washed 3 times. Goat anti-human IgG heavy and light chain or isotype-specific anti-IgG, -IgA, or -IgM labeled with alkaline phosphatase (Sigma Chemicals) was added at a predetermined optimal titer of 1:5000, and plates were incubated at 37ЊC for 2 h. The plates were washed 3 times and incubated with 50 mL of p-nitrophenylphosphate substrate until visible color change occurred. Absorbance was read at a wavelength of 405 nm. Titers corresponding to a 50% decrease in optical density levels were calculated by extrapolation based on a positive control sigmoid-binding curve of serum dilutions.
RESULTS
Establishing PCRs specific for individual SAGs. SAG genes may have considerable homology with one another. Therefore, specific PCRs able to distinguish S. aureus reference isolates were set up and used along with positive and negative controls. Figure 1 demonstrates that these PCRs are able to specifically detect the presence of individual SAG genes in the bacterial genome. Cross-reactions were not detected. Usually, there were no contaminant bands; the expected size of the amplification fragments was observed, based on comparisons with markers. The PCR results could be reliably confirmed in independent experiments and when using DNA preparations from sequentially subcloned colonies. Figure 1B shows how the highly homologous SEC1-3 could be distinguished on the basis of digestion of PCR products with 2 restriction enzymes, RsaI and HincII. The isolates BS51 and DE contained SEC3 and SEC2, respectively. S. aureus isolates from patients with TSS contain multiple SAG genes. Twelve isolates from patients with staphylococcal TSS were examined (figure 2). As expected, these isolates contained many SAG genes. The isolates had 3 features in common. First, they tended to have a high number of SAG genes per bacterial isolate (table 1) . Second, TSST1 was frequently present (figure 2), which is consistent with prior results [2] . Third, SEG and SEI were frequently present (figure 2), which is consistent with a recent report [9] .
The isolates from patients with TSS were a mixed collection. Eight were obtained at the height of a TSS epidemic in 1983 [3] ; 4 were recent isolates; 6 were from cases of menstrual TSS; 6 were from cases of nonmenstrual TSS; and 2 were from immunodeficient patients with atypical presentation of TSS [4] . There was no obvious correlation with these clinical groups in terms of SAG genes found by PCR. In most cases, the clinical expression of TSS could be explained by the presence of those toxins thought to mainly associate with TSS, namely TSST1, SEB, SEC [10] , and SEG, SEI [9] .
S. aureus isolates from female genital mucosa preferentially encode SEG and SEI. Several points can be made with regard to the PCR results for non-TSS isolates (figure 2). First, the overall frequency of SAG-positive isolates was 150% (table 1) . This is high, compared with frequencies in prior reports. The real frequency may be even higher, because new SAG genes are still being discovered [11, 12] . Indeed, rare isolates that gave negative results in all of our PCRs still produced supernatants with strong T cell stimulatory activity (bioassay for SAG), as discussed below.
Second, isolates that contained several SAG genes were quite common. This applied in particular to S. aureus isolates from female genital sites (table 1) but also to TSS isolates. Because TSS is thought to occur in persons who lack neutralizing antibodies to the SAG toxins [2] , bacteria with several SAG genes would be more likely to encounter a host lacking antibodies to any one of these SAG. Thus, selection for a group of isolates able to cause TSS symptoms may explain the high number of SAG genes in these isolates. However, it is not readily clear how selection may have occurred for the genital isolates with high numbers of SAG genes. By following the same argument, one might conclude that neutralizing antibodies to SEG, SEI, and TSST1 are less prevalent. This prediction was confirmed by the data ( figure 3A) , which show that, on average, antibody titers to TSST1, SEG, and SEI are lower than titers to SEA, SEB, and SEC2.
Third, bacteria from female genital sites frequently contained SEG and SEI ( figure 2 and table 1 ). This observation implies selection for this type of S. aureus at this site.
SAG genes are functional in vitro. SAG proteins are powerful T cell stimulants that are active at concentrations as low as 10 Ϫ15 M. Naive T cells proliferate vigorously with a rapid response, peaking after 3-4 days, as with mitogens. In contrast, T cell responses to nominal antigens usually require priming, are only detectable after 5-7 days of culture, and, in general, are low proliferative responses. These properties of SAGs make it possible to examine nonpurified bacterial supernatants for mitogenic activity [13, 14] . Indeed, bacteria that lacked SAG genes by PCR did not stimulate T cells to proliferate in a 3-day culture (figure 4 There were some exceptions to these rules. A few bacterial supernatants had activity in the T cell stimulation assay, even though no SAG was detected by PCR (data not shown). This was consistent with the presence of SAG genes that were either not evaluated in this study or with SAG genes that have yet to be discovered. Some bacterial supernatants containing SAG DNA by PCR were unable to induce T cell proliferation (e.g., BS29 and BS30). We confirmed the presence of SEC2 in BS29 and BS30 in several PCRs, but the bacterial supernatant was unable to induce T cell proliferation in [ 3 H]thymidine assays or by measuring expansion of Vb17 T cells known to be targeted by SEC2 [15] . We interpret these findings as evidence that SAG genes are sometimes not functionally expressed. Perhaps this is due to genetic variations and mutations or to regulation of SAG gene expression.
SEG and SEI stimulate specific Vb genes. To determine the Vb specificity of SEG and SEI, rSAG were added to PBL cultures at 10-fold dilutions of 10 Ϫ2 -10 Ϫ6 . T cells were stained after 7 days of culture with various MAbs to Vb gene products. SAG usually cause a shift of the targeted Vb subset into the blast population and an increase in total numbers of cells expressing the targeted Vb gene [15, 16] . For instance, SEI caused elevations of Vb1, Vb5.1, and Vb5.2 in the blast population, relative to the percentages in small resting T cells ( figure 5 ). Likewise, SEG stimulated Vb3 and Vb14. In experiments addressing the Vb specificity of SAG, results may vary, depending on the assay and on the concentration of the SAG used [17] . Our results on the specificity of SEG and SEI differed slightly from data obtained with a reverse-transcriptase PCR-based assay [11] . To assess whether concentration of the SAG affected the results, we titered rSEG and rSEI to dilutions of 10 Ϫ6 and used the same assay shown in figure   5 (data not shown). For rSEG, both Vb3 and Vb14 stimulation titered out at a dilution of 10 Ϫ4 . In contrast, the Vb-specific effects of rSEI were strikingly concentration dependent. Vb1 stimulation titered out at 10 Ϫ4 , Vb5.1 at 10 Ϫ5 , and Vb5.2 at
!10
Ϫ7 . Therefore, in the case of SEI, the observed Vb specificity depends greatly on its concentration. The SAG genes encoded in each S. aureus isolate vary tremendously (figure 2). One cannot predict how much of each SAG protein is produced by these isolates or whether this depends on the presence of other SAG genes or on environmental conditions. In addition, T cells stimulated simultaneously by several SAGs together may respond differently than T cells stimulated by individual SAGs. Therefore, in vivo, the Vbspecific effects of any given SAG are likely to be variable.
Women have evidence of higher antibody titers to SEG and SEI. On the basis of the observation that S. aureus from female genital mucosa, but not other tissue sites, express SEG and SEI, we predicted that women would have higher exposure to SEG and SEI and, therefore, higher average titers of serum antibodies specific for these 2 SAGs. We measured serum titers of IgG antibodies by ELISA, specifically for SEA, SEB, SEC2, TSST1, SEG, and SEI. Age-matched healthy donors from the New York area were used for this purpose. The average ages of the healthy donors were years (distribution, 17-47 33.2 ‫ע‬ 7.8 years) for women and years (distribution, 26-50 34.3 ‫ע‬ 9.7 years) for men. IgG titers for SEA, SEB, SEC2, and TSST1 did not differ in men and women, but average titers against SEG and SEI were higher in women ( figure 3A) . The difference reached statistical significance for anti-SEI titers.
Next we tested for IgM, IgA, and IgG antibodies to rSEI and rSEG (figure 3B). Women had high titers to rSEI and rSEG more frequently than men did. Although the trend was consistent regardless of antibody isotype (figure 3B), statistical significance was reached only for IgG and IgM titers to SEI.
Cord blood (CB) may contain maternal IgG but not IgM or IgA. Therefore, we also analyzed 3 random CB serum samples ( figure 3C ). Two of 3 CB serum samples contained IgG antibodies to rSEI and rSEG, presumably of maternal origin. As expected, IgM and IgA antibodies were completely lacking. This proves that antibodies to these SAGs are acquired, as opposed to innate. Development of antibody titers in children and adults likely requires exposure to S. aureus producing these toxins.
DISCUSSION
We present evidence that S. aureus from female genital mucosa express a different complement of SAG genes, frequently including SEG and SEI. This conclusion is based on 2 independent experimental results: PCR data on S. aureus isolates (figure 2) and higher average antibody titers to SEG and SEI in women. The data point to similarities between S. aureus isolated from patients with TSS and those from female genital sourcesnamely, both have more SAG genes per bacterium, and they frequently contain SEG/SEI. The isolated bacteria encoded functionally intact SAGs with the clear potential for in vivo biologic effects. Thus, it seems possible that these SAG genes provide the bacteria with an adaptive mechanism suited to their environment.
Role for SEG/SEI? The genes for most SAGs are located on mobile genetic elements called pathogenicity islands (SaPIs) [18, 19] . TSST1 is located on SaPIn1. The genes for SEG and SEI are located within a cluster of SAG genes on SaPIn3. SaPIs can spread horizontally. They are excised, replicated, and encapsidated as phagelike particles and, finally, integrated as intact units by an integrase encoded within the SaPI itself [18] . This explains why the SEG and SEI genes are usually present together (figure 2). Bacterial strains associated with TSS appear to contain both pathogenicity islands, SaPIn1 and SaPIn3. Such strains would contain numerous additional toxin genes encoded on these islands. For instance, SaPIn3 also contains leukotoxins (lukD and lukE) and a series of secretory serine pro- teases (splA-F) [19] . In addition to SAGs, these genes are also candidates that may provide S. aureus with adaptive mechanisms for survival in the environment of the genital mucosa.
This may arguably be the first example in which S. aureus isolated from a particular tissue expresses an alternative set of SAG genes. As such, the data suggest that SEG/SEI provide bacteria with an advantage specific to the female genital mucosa. However, as discussed, SEG/SEI may serve solely as genetic markers for specific SaPIs.
There is one other instance in which expression of specific SAGs may be associated with a specific infection: chronic mastitis in cows. These infections are persistent and resolve poorly [20, 21] . In one study, they were associated with S. aureus in 37% of cases [22] . Such isolates most frequently produce SEC, rather than other SAGs tested, on the basis of results of Southern blot and immunodiffusion with specific antiserum [23] . Here, SEC may serve as a marker for the presence of another pathogenicity island (e.g., SaPI4 or SaPIbov) [18] .
Are bacteria containing SEG/SEI adapted for genital colonization or invasion? If SEG/SEI-containing S. aureus predominate in cultures from female genital mucosa, the question arises whether these genes themselves or other genes on SaPIn3 can facilitate colonization or invasion of the genital mucosa. SAG genes belong to the complement of genes expressed during the stationary phase of S. aureus growth in vitro [24] , a phase thought to reflect in vivo tissue invasion. Indeed, SAGs are expressed along with other extracellular enzymes and toxins (lipase, V8 protease, leukocidin, staphylokinase, hemolysins, phospholipase, elastase, and hyaluronidase) that are likely to aid in tissue invasion. However, S. aureus isolates from patients with TSS make significantly fewer hemolysins, nucleases, and lipases than do isolates from wounds or nares [25] . Similar observations were made with vaginal isolates from healthy menstruating or nonmenstruating women [25] . Thus, these isolates may be less well endowed with secretory products that are thought to be important in tissue invasion. This is now better understood, because it has been shown that TSST1 and SEB are global repressors of exotoxin synthesis, and SAG-producing strains of S. aureus are apurulent, inhibit inflammation, and fail to produce an abscess when inoculated subcutaneously in mice [26] .
In our study, genital S. aureus was isolated most often from patients with vaginal discharge or a local infection. In most cultures, S. aureus was not the predominating microorganism, with the notable exception of BS49 and BS47 from patients with vaginitis, where methicillin-resistant S. aureus overgrew other bacterial species. Even though S. aureus is not a common pathogen in the vagina/cervix, we consider it possible that S. aureus may have contributed to the infection in the absence of any other known causative organism. If so, it remains possible that SEG/SEI may have facilitated invasion of the genital mucosa, leading to infection. Indeed, there is evidence that some SAGs can have striking effects on mucosal epithelia [27] , presumed to be the cause of food poisoning, and that they can transcytose through unicellular epithelial layers [28] and stimulate T cells after transepithelial transport in mice [28] .
S. aureus can be isolated from normal female genital mucosa, especially during menstruation [2] , or from used tampons. In one study, vaginal carriage of S. aureus was 7% in premenarchial and nonmenstruating women but 33% in menstruating women [2] . In another study [29] , S. aureus carriage persisted for the duration of 3 menstrual cycles in 6 (35%) of 17 colonized women. This raises the possibility that S. aureus may occasionally colonize the female genital mucosa.
There are quite obvious differences between female genital mucosa and other epithelia, in particular, the cyclical menstrual changes. S. aureus containing SEG/SEI genes might differ from other S. aureus strains when tested with relevant experimental variables such as pH, viscosity of vaginal mucus, content of antimicrobial enzymes (e.g., lysozyme) vaginal iron, lactoferrin, H 2 O 2 produced by lactobacilli, oxidation-reduction potential, and local IgA and IgG antibodies. In an attempt to address these issues, we tested 170 cervicovaginal cultures from healthy nonmenstruating women seen for routine gynecologic examinations. Only 1 sample grew S. aureus. Of 12 SAG genes examined by PCR, this isolate contained SEG, SED, and SEA (data not shown). In summary, further studies are needed to examine how SEG/SEI or other genes of SaPIn3 provide S. aureus with an adaptive mechanism for growth in cervicovaginal tissues.
